BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 27647460)

  • 1. Young adult breast cancer patients have a poor prognosis independent of prognostic clinicopathological factors: a study from the Japanese Breast Cancer Registry.
    Kataoka A; Iwamoto T; Tokunaga E; Tomotaki A; Kumamaru H; Miyata H; Niikura N; Kawai M; Anan K; Hayashi N; Masuda S; Tsugawa K; Aogi K; Ishida T; Masuoka H; Iijima K; Kinoshita T; Nakamura S; Tokuda Y
    Breast Cancer Res Treat; 2016 Nov; 160(1):163-172. PubMed ID: 27647460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological implications of Tiam1 overexpression in invasive ductal carcinoma of the breast.
    Li Z; Liu Q; Piao J; Hua F; Wang J; Jin G; Lin Z; Zhang Y
    BMC Cancer; 2016 Aug; 16(1):681. PubMed ID: 27562113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Clinicopathological Factors Associated with Disease Progression in Luminal A Breast Cancer and Characteristics of Metastasis: A Retrospective Study from A Single Center in China.
    Ye J; Wang W; Xin L; Owen S; Xu L; Duan X; Cheng Y; Zhang H; Zhang S; Li T; Liu Y
    Anticancer Res; 2017 Aug; 37(8):4549-4556. PubMed ID: 28739751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients].
    Guan Y; Xu BH; Li Q; Zhang P; Zhao LM; Yuan P; Wang JY
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):77-81. PubMed ID: 18353207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the TNM classification of solitary internal mammary lymph node metastases in breast cancer still apply?
    Habraken V; van Nijnatten TJ; de Munck L; Moossdorff M; Heuts EM; Lobbes MB; Smidt ML
    Breast Cancer Res Treat; 2017 Feb; 161(3):483-489. PubMed ID: 27915433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic effect of estrogen receptor status differs for younger versus older breast cancer patients.
    Sopik V; Sun P; Narod SA
    Breast Cancer Res Treat; 2017 Sep; 165(2):391-402. PubMed ID: 28601929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer.
    Wang R; Zhu Y; Liu X; Liao X; He J; Niu L
    BMC Cancer; 2019 Nov; 19(1):1091. PubMed ID: 31718602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological characteristics, diagnosis, and prognosis of pregnancy-associated breast cancer.
    Wang B; Yang Y; Jiang Z; Zhao J; Mao Y; Liu J; Zhang J
    Thorac Cancer; 2019 May; 10(5):1060-1068. PubMed ID: 30920126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the CPS+EG and Neo-Bioscore staging systems after preoperative systemic therapy for breast cancer in a single center in China.
    Xu L; Duan X; Zhou B; Liu Y; Ye J; Liu Z; Ma C; Zhang H; Zhang S; Zhang L; Zhao J; Cheng Y
    Breast; 2018 Aug; 40():29-37. PubMed ID: 29677568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrine sensitivity is decisive for patient outcome in small node-negative breast cancers (BC) (pT1a,b) - results from the Munich Cancer Registry.
    Kolben T; Harbeck N; Wuerstlein R; Schubert-Fritschle G; Bauerfeind I; Schrodi S; Engel J
    Breast; 2015 Feb; 24(1):24-31. PubMed ID: 25543874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The lymph node ratio as an independent prognostic factor for non-metastatic node-positive breast cancer recurrence and mortality.
    Solak M; Turkoz FP; Keskin O; Aksoy S; Babacan T; Sarici F; Kertmen N; Sever AR; Altundag K
    J BUON; 2015; 20(3):737-45. PubMed ID: 26214625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of Young Age for Prognosis by Subtype in Women with Early Breast Cancer.
    Lian W; Fu F; Lin Y; Lu M; Chen B; Yang P; Zeng B; Huang M; Wang C
    Sci Rep; 2017 Sep; 7(1):11625. PubMed ID: 28912475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation and prognostic value of SIRT1 and Notch1 signaling in breast cancer.
    Cao YW; Li WQ; Wan GX; Li YX; Du XM; Li YC; Li F
    J Exp Clin Cancer Res; 2014 Nov; 33(1):97. PubMed ID: 25420528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological characteristics of breast cancer and trends in the management of breast cancer patients in Japan: Based on the Breast Cancer Registry of the Japanese Breast Cancer Society between 2004 and 2011.
    Kurebayashi J; Miyoshi Y; Ishikawa T; Saji S; Sugie T; Suzuki T; Takahashi S; Nozaki M; Yamashita H; Tokuda Y; Nakamura S
    Breast Cancer; 2015 May; 22(3):235-44. PubMed ID: 25758809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Outcomes and Prognostic Factors of Pathologic N3 Breast Cancer Treated With Modern Standard Treatments.
    Yu JI; Park W; Choi DH; Huh SJ; Nam SJ; Kim SW; Lee JE; Kil WH; Im YH; Ahn JS; Park YH; Cho EY
    Clin Breast Cancer; 2015 Dec; 15(6):512-8. PubMed ID: 26188791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PD-L1 expression and tumor infiltrating PD-1+ lymphocytes associated with outcome in HER2+ breast cancer patients.
    Tsang JY; Au WL; Lo KY; Ni YB; Hlaing T; Hu J; Chan SK; Chan KF; Cheung SY; Tse GM
    Breast Cancer Res Treat; 2017 Feb; 162(1):19-30. PubMed ID: 28058578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Young breast cancer patients who develop distant metastasis after surgery have better survival outcomes compared with elderly counterparts.
    Wang J; Wang J; Li Q; Zhang P; Yuan P; Ma F; Luo Y; Cai R; Fan Y; Chen S; Li Q; Xu B
    Oncotarget; 2017 Jul; 8(27):44851-44859. PubMed ID: 28206957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of Rsf-1 correlates with pathological type, p53 status and survival in primary breast cancer.
    Ren J; Chen QC; Jin F; Wu HZ; He M; Zhao L; Yu ZJ; Yao WF; Mi XY; Wang EH; Wei MJ
    Int J Clin Exp Pathol; 2014; 7(9):5595-608. PubMed ID: 25337201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNM classification and the need for revision of pN3a breast cancer.
    van Nijnatten TJA; Moossdorff M; de Munck L; Goorts B; Vane MLG; Keymeulen KBMI; Beets-Tan RGH; Lobbes MBI; Smidt ML
    Eur J Cancer; 2017 Jul; 79():23-30. PubMed ID: 28458119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between body mass index and the expression of hormone receptors or human epidermal growth factor receptor 2 with respect to breast cancer survival.
    Jeon YW; Kang SH; Park MH; Lim W; Cho SH; Suh YJ
    BMC Cancer; 2015 Nov; 15():865. PubMed ID: 26546331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.